Cargando…
Asenapine for bipolar disorder
Asenapine (Saphris(®)) is an atypical antipsychotic drug which has been approved by the US Food and Drug Administration for the treatment of schizophrenia in adults, as well as the treatment of acute manic or mixed episodes of bipolar I in both adult and pediatric populations. Asenapine is a tetracy...
Autores principales: | Scheidemantel, Thomas, Korobkova, Irina, Rej, Soham, Sajatovic, Martha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675633/ https://www.ncbi.nlm.nih.gov/pubmed/26674884 http://dx.doi.org/10.2147/NDT.S78043 |
Ejemplares similares
-
A Review of Asenapine in the Treatment of Bipolar Disorder
por: Vieta, Eduard, et al.
Publicado: (2017) -
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
por: Bishara, Delia, et al.
Publicado: (2009) -
Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
por: Lachaine, Jean, et al.
Publicado: (2014) -
Asenapine augmentation in bipolar disorders: a case series
por: Marazziti, Donatella, et al.
Publicado: (2016) -
COVID‐19 and older adults with bipolar disorder: Problems and solutions
por: Almeida, Osvaldo P., et al.
Publicado: (2021)